Frontier Bio Corporation
Frontier Bio is a biotechnology company dedicated to creating lab-grown human tissues to replace animal studies, advance regenerative medicine, and develop engineered organs. Their mission is to revolutionize disease treatment and organ replacement through cutting-edge tissue engineering, with a vision of a future where organ donors are no longer needed and animal testing is a thing of the past.
Industries
Nr. of Employees
small (1-50)
Frontier Bio Corporation
Patents
System and method for creating an object with a conduit with particular vascular applications
US-12435446-B2
View DetailsEmploying human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
US-10273461-B2
View Details
System and method for creating an object with a conduit with particular vascular applications
US-12435446-B2
View DetailsEmploying human adipose-derived stem cells to propagate serum-derived hepatitis C virus and use thereof
US-10273461-B2
View DetailsProducts
3D-bioprinted lung microtissue
Distal lung microtissue produced by 3D bioprinting combined with stem cell self-assembly, containing bronchioles, alveolar structures, vasculature, and functional features such as cilia, mucus, and surfactant.
Microfluidic blood–brain barrier chip
Organ-on-chip BBB platform that supports continuous barrier formation and neurovascular unit assembly for studies of transport, toxicity, and disease mechanisms.
Vascularized neural spheroids
Three-dimensional neural spheroids with integrated vasculature to improve nutrient/oxygen delivery and enhance functional readouts for screening and modeling.
Tissue-engineered blood vessels and aneurysm models
Living blood vessel constructs created by seeding cells onto biodegradable scaffolds and matured under biomimetic conditions; models include pathological geometries such as aneurysms for device testing.
Synthetic vascular simulation models (mechanical vessel mimics)
Non-living vessel simulants with mechanical and handling characteristics similar to native vessels for preclinical development and surgical rehearsal.
3D-bioprinted lung microtissue
Distal lung microtissue produced by 3D bioprinting combined with stem cell self-assembly, containing bronchioles, alveolar structures, vasculature, and functional features such as cilia, mucus, and surfactant.
Microfluidic blood–brain barrier chip
Organ-on-chip BBB platform that supports continuous barrier formation and neurovascular unit assembly for studies of transport, toxicity, and disease mechanisms.
Vascularized neural spheroids
Three-dimensional neural spheroids with integrated vasculature to improve nutrient/oxygen delivery and enhance functional readouts for screening and modeling.
Tissue-engineered blood vessels and aneurysm models
Living blood vessel constructs created by seeding cells onto biodegradable scaffolds and matured under biomimetic conditions; models include pathological geometries such as aneurysms for device testing.
Synthetic vascular simulation models (mechanical vessel mimics)
Non-living vessel simulants with mechanical and handling characteristics similar to native vessels for preclinical development and surgical rehearsal.
Services
Collaborative design and execution of research plans to develop human-relevant tissue models tailored to partner research questions.
Preclinical evaluation of vascular device deployment and tissue-device interactions using living engineered vessels and aneurysm models.
In vitro assays for drug transport, efficacy, and neurotoxicity using microfluidic BBB chips, vascularized neurospheres, and 3D lung microtissues.
Collaborative design and execution of research plans to develop human-relevant tissue models tailored to partner research questions.
Preclinical evaluation of vascular device deployment and tissue-device interactions using living engineered vessels and aneurysm models.
In vitro assays for drug transport, efficacy, and neurotoxicity using microfluidic BBB chips, vascularized neurospheres, and 3D lung microtissues.
Expertise Areas
- Tissue engineering
- 3D bioprinting
- Organ-on-chip (blood–brain barrier) modeling
- Vascular tissue engineering
Key Technologies
- 3D bioprinting
- Stem cell differentiation and self-assembly
- Microfluidics (organ-on-chip)
- Biodegradable polymer scaffolds
News & Updates
Frontier Bio announced a groundbreaking achievement in lab-grown lung tissue, combining 3D bioprinting with stem cell self-assembly to create complex microscale lung tissue, paving the way for advancements in treating respiratory diseases and organ transplantation.
Frontier Bio was recognized with a nomination for the 3D Printing Industry Awards 2024, highlighting its progress in healthcare innovation through 3D bioprinting.
Frontier Bio announced a groundbreaking achievement in lab-grown lung tissue, combining 3D bioprinting with stem cell self-assembly to create complex microscale lung tissue, paving the way for advancements in treating respiratory diseases and organ transplantation.
Frontier Bio was recognized with a nomination for the 3D Printing Industry Awards 2024, highlighting its progress in healthcare innovation through 3D bioprinting.